Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/07/1994 | WO1994011508A3 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
07/07/1994 | WO1994011507A3 Production of monoclonal recombinant antibodies without the use of hybridomas by in vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna |
07/07/1994 | WO1994011503A3 Chimeric factor viii |
07/07/1994 | WO1994011502A3 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
07/07/1994 | WO1994010317A3 Conjugate vaccine against group b streptococcus |
07/07/1994 | WO1994010207A3 Truncated insulin-like growth factor binding proteins having mitogenic activity |
07/07/1994 | WO1994006918A3 Transformation of phaffia rhodozyma |
07/07/1994 | WO1994005791A3 Dorsal tissue affecting factor and compositions |
07/07/1994 | WO1993022433A3 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |
07/07/1994 | DE4244541A1 New HIV-type immune deficiency virus ECACC V 92092318 |
07/07/1994 | CA2152599A1 Novel neutrophil inhibitors |
07/07/1994 | CA2152501A1 Sequence-directed dna-binding molecules compositions and methods |
07/07/1994 | CA2152256A1 Vaccines against varicella-zoster virus (vzv) |
07/07/1994 | CA2151156A1 New protein from urine named component b |
07/07/1994 | CA2151038A1 Modified cutinases, dna, vector and host |
07/07/1994 | CA2150922A1 4-benzoyl isoxazoles derivatives and their use as herbicides |
07/07/1994 | CA2150837A1 Modified cutinases, dna, vector and host |
07/07/1994 | CA2150670A1 Method and apparatus for enzymatic synthesis of oligonucleotides |
07/07/1994 | CA2149630A1 Analytical technique for oligonucleotide analogs |
07/07/1994 | CA2130561A1 Modified tcf |
07/07/1994 | CA2129992A1 Cloning and expression of xylanase b |
07/07/1994 | CA2127797A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus |
07/06/1994 | EP0605139A2 A method for producing azadirachtin |
07/06/1994 | EP0605073A2 Molecular cloning and expression of neutral protease genes |
07/06/1994 | EP0605040A1 Pullulanase, micro-organisms producing the same, method for preparation thereof as well as its use |
07/06/1994 | EP0604706A1 Production of human parathyroid hormone from microorganisms |
07/06/1994 | EP0604662A1 Method of transforming monocotyledon |
07/06/1994 | EP0604647A1 Alleviation of symptoms associated with inflammatory disease states |
07/06/1994 | EP0604624A1 Multimeric forms of human rhinovirus receptor protein |
07/06/1994 | EP0604603A1 Cadherin materials and methods |
07/06/1994 | EP0604584A1 Factors for the cellular functional regulation and biological applications thereof |
07/06/1994 | EP0604580A1 EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
07/06/1994 | EP0604566A1 Chimeric and/or growth-restricted flaviviruses |
07/06/1994 | EP0604560A1 Human cyclin e |
07/06/1994 | EP0604552A1 Method of synthesizing diverse collections of oligomers. |
07/06/1994 | EP0604551A1 New cell lines which support replication of baculoviruses |
07/06/1994 | EP0604506A1 Gene probe biosensor method |
07/06/1994 | EP0604495A1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use. |
07/06/1994 | EP0604488A1 Polypeptides, inhibitors of the replication of hsu and similar viruses |
07/06/1994 | EP0604458A1 Nucleotide sequences of galactinol synthase from zucchini and soybean |
07/06/1994 | EP0604429A1 Novel yeast strains for the production of xylitol |
07/06/1994 | EP0604418A1 Isolated viral protein cytokine antagonists |
07/06/1994 | EP0604409A1 Compositions and methods for detecting and modulating rna activity and gene expression |
07/06/1994 | EP0374157B1 A new class of low calorie protein sweeteners |
07/06/1994 | EP0324788B1 Peptide fragment capable of binding to laminin |
07/06/1994 | EP0248896B1 Amplified hybridization assay |
07/06/1994 | EP0216854B1 Monoclonal antibodies and assay |
07/06/1994 | EP0205475B1 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
07/06/1994 | CN1088986A Reshaped monoclonal antibodies against an immunoglobulin isotype |
07/06/1994 | CN1088836A Recombined hirudin and its compound useful for preparation of medicine for preventing and treating thrombosis |
07/05/1994 | US5326860 Pituitary adenylate cyclase activating protein precursor |
07/05/1994 | US5326859 DNA and recombinant plasmid |
07/05/1994 | US5326858 Genetic engineering; antiarthritic agents |
07/05/1994 | US5326857 ABO genotyping |
07/05/1994 | US5326700 DNA sequences encoding t-PA derivatives with cleavable sites |
07/05/1994 | US5326692 Fluorescent microparticles with controllable enhanced stokes shift |
07/05/1994 | US5326691 Gene cloning |
07/05/1994 | US5326580 Heat resistant protein with long-lasting taste |
07/05/1994 | US5326558 Megakaryocytopoietic factor |
07/05/1994 | CA2112652A1 New transdominant tat variants for hiv virus |
07/05/1994 | CA2112645A1 Flow-through hybridization assay for oligonucleotide sequences |
07/01/1994 | EP0724633A4 Recombinant transferrins, transferrin half-molecules and mutants thereof |
07/01/1994 | CA2112716A1 Biocompatible medical devices |
07/01/1994 | CA2112527A1 Mechanism-based screen for retinoid x receptor agonists and antagonists |
07/01/1994 | CA2112445A1 Method for monitoring pesticide resistance |
07/01/1994 | CA2092258A1 Synchronized donor cells for bovine nuclear transfer |
07/01/1994 | CA2086577A1 Potential target for immunotherapy to prevent replication of hiv (aids virus) in humans: cdna and protein for a putative regulator of hiv gag polyprotein expression reconstructed from the antisense strand of human p53 gene |
06/29/1994 | EP0604224A1 Porcine GRF receptor |
06/29/1994 | EP0604060A1 A process for producing riboflavin |
06/29/1994 | EP0603865A2 Process for producing alanine |
06/29/1994 | EP0603735A2 Monoclonal antibodies that define a unique antigen of human B-cell antigen receptor complex |
06/29/1994 | EP0603672A2 Process for the production of recombinant and synthetic peptides and their use |
06/29/1994 | EP0603416A1 METHOD OF INTEGRATING GENE INTO CHROMOSOME OF $i(LACTOBACILLUS DELBRUECKII) SPECIES AND PRODUCT OF GENE INTEGRATION |
06/29/1994 | EP0603406A1 Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same |
06/29/1994 | EP0603371A1 Genes for altering plant metabolism |
06/29/1994 | EP0603312A1 Novel gaba a? receptor with steroid binding sites |
06/29/1994 | EP0603307A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
06/29/1994 | EP0603263A1 Yeast artificial chromosomes and their use in the control of gene expression |
06/29/1994 | EP0603250A1 Modification of lignin synthesis in plants |
06/29/1994 | EP0603216A1 Biocidal proteins |
06/29/1994 | EP0603215A1 Purification of factor xiii. |
06/29/1994 | EP0603205A1 Methods for determining susceptibility to lead poisoning |
06/29/1994 | EP0603190A1 Plant-derived enzyme and dna sequences, and uses thereof |
06/29/1994 | EP0603187A1 Human lactoferrin |
06/29/1994 | EP0444118B1 Pyruvate-kinase-isoenzyme-type-m2 (tumour m2-pk) specific antibodies, process for producing them and use |
06/29/1994 | EP0406272B1 Production of insulin-like growth factor binding protein |
06/29/1994 | EP0401303B1 Novel human tissue plasminogen activator variants and processes |
06/29/1994 | CN1025219C Monoclonal antibody specific to HTV antigens |
06/28/1994 | US5324830 Chimeric protein that has a human RHo Motif and deoxyribonuclease activity |
06/28/1994 | US5324818 Proteins containing DNA or RNA sequences which control gene expression |
06/28/1994 | US5324731 Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated |
06/28/1994 | US5324715 Protein for inhibiting collagen-stimulated platelet aggregation |
06/28/1994 | US5324664 Geneically engineered vaccines for cats |
06/28/1994 | US5324663 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
06/28/1994 | US5324660 Deficient in proteolytic activity; useful as hosts for expression of proteolytically sensitive recombinant products |
06/28/1994 | US5324659 Yeast mutants useful for indentifying immunosupressants |
06/28/1994 | US5324655 Human Y-interferon signal peptide-tumor necrosis factor(TNF) gene fusions |
06/28/1994 | US5324654 Method for reversibly increasing proliferation of a non-malignant cell population |
06/28/1994 | US5324653 Substituting amino acid from polypeptide chain at selective positions, differs at least in one amino acid from wild type enzyme; used in laundary detergent; antisoilant; storage stabilitly |
06/28/1994 | US5324651 Useful as reagent for studying cellular signal transduction mechanism |